You are here: Home » PTI Stories » National » News
Business Standard

USFDA completes inspection of J B Chemicals' Panoli facility with two observations

Press Trust of India  |  New Delhi 

J B Chemicals and Pharmaceuticals today said the US health regulator has completed inspection of its facility in with two minor observations.

"The company's at Panoli, has successfully passed periodical inspection by (USFDA) with two minor procedural observations," J B Chemicals and Pharmaceuticals said in a BSE filing.

The company said these observations do not impact continuity of its business and it would continue its in Current Good Manufacturing Practice (CGMP) compliant manner.

"The company proposes to address these observation in next 30 days," it added.

The inspection was carried out from May 7 to May 11, 2018.

This US FDA/EU/approved facility primarily manufactures APIs for exports to EU and formulations exports to US, it said.

The stock was trading at Rs 311.15, down 2.80 per cent, on BSE.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, May 14 2018. 11:35 IST